Literature DB >> 13316545

The treatment of cancer of the thyroid gland.

L H GARLAND.   

Abstract

The optimum treatment for cancer of the thyroid depends on (a) the pathological type of tumor present and (b) the stage of the disease.In patients with well-differentiated papillary carcinoma, simple operation is usually adequate. In cases of most other types, more extensive operation, followed by adequate postoperative radiotherapy, is regarded as the treatment of choice. In terms of clinical stage, the primary treatment of most cases classified as Stage I or II should be surgical, and of most cases classified as Stage III or IV, radiological. The five-year survival rate in a series of nonterminal cases treated under such a program was 47 per cent. Persistent treatment of selected inoperable or metastatic lesions may result in unexpectedly long survivals.

Entities:  

Keywords:  RADIOTHERAPY; THYROID GLAND/neoplasms

Mesh:

Year:  1956        PMID: 13316545      PMCID: PMC1531823     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  7 in total

1.  Thyroid carcinoma in children.

Authors:  T WINSHIP; W W CHASE
Journal:  Surg Gynecol Obstet       Date:  1955-08

2.  Treatment of carcinoma of the thyroid.

Authors:  F JACOBSSON
Journal:  Acta radiol       Date:  1954-02       Impact factor: 1.990

3.  Surgical statistics on malignant goiter.

Authors:  J E SOKAL
Journal:  Surg Gynecol Obstet       Date:  1954-07

4.  Carcinoma of the thyroid; a re-evaluation.

Authors:  R C HORN; J A DULL
Journal:  Ann Surg       Date:  1954-01       Impact factor: 12.969

5.  Carcinoma of the thyroid; a clinicopathologic study.

Authors:  H N CRABTREE; D C HUNTER
Journal:  AMA Arch Surg       Date:  1953-08

6.  Clinical and pathological review of the nodular thyroid.

Authors:  J E KEARNS; H DAVIS
Journal:  AMA Arch Surg       Date:  1952-05

7.  Cancer of the thyroid.

Authors:  G CRILE
Journal:  J Clin Endocrinol Metab       Date:  1950-09       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.